VEGFA and gastric cancer: In patients with advanced gastric cancer, pharmacologic agents that specifically targeting VEGF ligand, or receptors by specific kinase inhibitors or antibodies, exhibited efficacy in clinical trials in combination with chemotherapy or not [3].